N-(1,2,3,5,6,7-hexahydros-indacen-4-ylcarbamoyl)-2-(5-methylthiazol-2-yl)ethenesulfonamide

ID: ALA4760079

PubChem CID: 137528022

Max Phase: Preclinical

Molecular Formula: C19H21N3O3S2

Molecular Weight: 403.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cnc(/C=C/S(=O)(=O)NC(=O)Nc2c3c(cc4c2CCC4)CCC3)s1

Standard InChI:  InChI=1S/C19H21N3O3S2/c1-12-11-20-17(26-12)8-9-27(24,25)22-19(23)21-18-15-6-2-4-13(15)10-14-5-3-7-16(14)18/h8-11H,2-7H2,1H3,(H2,21,22,23)/b9-8+

Standard InChI Key:  JJIXBPUOOSHJCK-CMDGGOBGSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    4.5400  -18.0484    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.9527  -18.7624    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    5.3652  -18.0459    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.8020  -18.7647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2252  -17.9374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.8032  -17.9410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5106  -17.5295    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3405  -16.7306    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5279  -16.6467    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1943  -17.3939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2280  -18.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5193  -19.1740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.6913  -19.9748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5064  -20.0575    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.8354  -19.3077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0904  -19.1737    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3784  -18.7655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6668  -19.1745    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3779  -17.9442    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2472  -19.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5329  -18.7710    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.8236  -19.1838    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0671  -18.8549    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.5199  -19.4696    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9369  -20.1790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7392  -20.0000    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.6049  -20.9275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  6  4  2  0
  4 12  1  0
 11  5  1  0
  5  7  2  0
  6  7  1  0
  7  8  1  0
  8  9  1  0
  9 10  1  0
 10  6  1  0
 11 12  2  0
 12 13  1  0
 13 14  1  0
 14 15  1  0
 15 11  1  0
  4 16  1  0
 16 17  1  0
 17 18  1  0
 17 19  2  0
 18  2  1  0
  2 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  1  0
 25 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4760079

    ---

Associated Targets(Human)

NLRP3 Tchem NACHT, LRR and PYD domains-containing protein 3 (908 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 403.53Molecular Weight (Monoisotopic): 403.1024AlogP: 3.55#Rotatable Bonds: 4
Polar Surface Area: 88.16Molecular Species: ACIDHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 3.74CX Basic pKa: 2.97CX LogP: 3.86CX LogD: 3.30
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.82Np Likeness Score: -0.97

References

1. Agarwal S,Pethani JP,Shah HA,Vyas V,Sasane S,Bhavsar H,Bandyopadhyay D,Giri P,Viswanathan K,Jain MR,Sharma R.  (2020)  Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor.,  30  (21.0): [PMID:32980515] [10.1016/j.bmcl.2020.127571]

Source